Comparison of efficacy between intralesional bleomycin and cryotherapy in plantar warts
Keywords:
Intralesional, bleomycin, plantar warts, cryotherapyAbstract
Objective To compare the efficacy of intralesional bleomycin and cryotherapy in treating plantar warts. Material and Methods A total of 160 patients (80 in each group) were enrolled, who were randomly divided into 2 groups. Group A was treated with 0.1% intralesional bleomycin and group B was treated with liquid nitrogen with a cotton swab. Follow-up was carried out at 02, 04 and 06 weeks and the final efficacy was calculated at the end of 06 weeks. Results Out of 160 patients, 32 (40.0%) male and 48 (60.0%) female were enrolled in intralesional bleomycin group; 30(36.5%) male and 50 (62.5%) females were included in cryotherapy group. Mean±SD of age in intralesional bleomycin and cryotherapy was 28.24±4.2 with C.I (27.30-29.17) and 27.56±3.8 with C.I (26.71-28.40) years, respectively. In comparison of both groups 90% efficacy was found in intralesional bleomycin group whereas 72.5% in cryotherapy group and p value was found to be highly significant i.e. (P=0.005). Conclusion Intralesional bleomycin is more effective than cryotherapy in the treatment plantar warts.References
Lowy DR, Androphy EJ. Warts. In: Freedberg IM, Eisen AZ,Wolf K, Austen KF, Goldsmith LA, Katz SI, eds.Fitzpatrick’sDermatology in General Medicine. Vol. 4, 6th ed. New York: McGraw-Hill; 2003. p. 2119-30, 2358,2575-80.
Bacelieri R, Johnson SM. Cutaneous wart: An evidence basedapproach to therapy. Am Fam Physician 2005; 72: 647-52.
James WD, Berger TG, Elston DM. Viral Diseases. In: James WD,Berger TG, Elston DM, eds. Andrews, disease of skin: Clinical dermatology. 10th ed. Philadelphia: Saunders Elsevier; 2006. p. 403-15.
Haribhakti PB, Macwan R. Viral skin infections. In: Valia RG,Valia AR, eds. IADVL Textbook and Atlas of Dermatology. 2nd ed. Mumbai: Bhalani Publishing House; 2001. p. 303-9.
Sterling JC. Virus infections. In: Burns T, Breathnach S, CoxN, Griffiths C, eds.Rook’s Textbook of Dermatology. Vol. 27thed. Massachuesttes: Blackwell Science; 2004. p. 25.39-57.
Sterling JC, Handfield-Jones S, Hudson PM. Guidelines for the management of cutaneous warts. Br J Dermatol 2001; 144: 4-11.
Ryu HR, Jeong HR, Seon-Woo HS et al. Drug Deliv and Transl Res 2018; 8: 273.
Gibbs S, Harvey I, Sterling J, Stark R. Local treatments for cutaneous warts: systematic review. BMJ 2002; 325(7362): 461.
Agius E, Mooney JM, Bezzina AC, Yu RC. Dermojet delivery of bleomycin for the treatment of recalcitrant plantar warts. J Dermatol Treat 2006; 17:112-6.
Bunney MH, Nolan MW, Buxton PK, Going SM, Prescott RS. The treatment of resistant warts with intralesional bleomycin: A controlled clinical trial. Br J Dermatol 1984; 11:197-207.
Munn SE, Higgins E, Marshall M, Clement M. A new method of intralesional bleomycin therapy in the treatment of recalcitrant warts. Br J Dermatol 1996; 135: 969-71.
Shelley WB, Shelley ED. Intralesional bleomycin sulfate therapy for warts: A novel bifurcated needle puncture technique. Arch Dermatol 1991; 127: 234-6.
Hayes ME, O'keefe EJ. Reduced dose of bleomycin in the treatment of recalcitrant wart. J Am Acad Dermatol 1986; 15: 1002-6.
Bourke JF, Berth-Jones J, Hutchinson PE. Cryotherapy of common viral warts at intervals of 1, 2 and 3 weeks. Br J Dermatol 1995; 132: 433-6.
Adalatkhah H, Khalilollahi H, Amini N, Sadeghi-Bazargani H. Compared therapeutic efficacy between intralesional bleomycin and cryotherapy for common wart: A randomized clinical trial. Dermatol Online J 2007; 13: 4.